Lapatinib Completed Phase 2 Trials for 70 Years Old Patients and Over / After One Line of Chemotherapy With Trastuzumab / Metastatic Breast Cancer (MBC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00694252Lapatinib and Circulating Tumor Cells in Breast Cancer
NCT02338245Study of ASLAN001 in Combination With Capecitabine in MBC That Has Failed on Prior Trastuzumab
NCT01262469Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer.